Please wait

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Enveric Biosciences, Inc.

(Exact Name of Each Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type		Security Class Title		Fee Calculation or Carry Forward Rule		Amount Registered ⁽¹⁾				Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price				Fee Rate				Amount of Registration Fee
Equity		Common Stock, par value $0.01 per share (“Common Stock”)		Rule 457(c) and Rule 457(h)			375,671			$1.75 ⁽²⁾		$	657,424.00				0.00015310			$	100.65
Total Offering Amounts												$	657,424.00				0.00015310			$	100.65
Total Fees Previously Paid																					-
Total Fee Offsets																					-
Net Fee Due																				$	100.65

(1)	Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered hereunder includes such additional number of shares of common stock, par value $0.01 per share (the “Common Stock”) of Enveric Biosciences, Inc. (the “Company”), as are required to prevent dilution resulting from a stock split, stock dividend or similar transaction. Includes (i) 50,279 shares of Common Stock issued or issuable pursuant to restricted stock units and/or restricted stock awards outstanding under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the “Incentive Plan”), and (ii) 325,392 shares of Common Stock that are reserved for issuance pursuant to future awards under the Incentive Plan.

(2)	The offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon the average of high and low prices reported by the Nasdaq Capital Market on March 20, 2025, a date within five (5) business days prior to the date of the filing of this Registration Statement.